GregoryN.FullerMD

Cytopathology, Neuropathology, Anatomic Pathology, Clinical Pathology

Professor of Pathology Chief, Section of Neuropathology

Dr. Fuller is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

249 citations
Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.
Amy B. Heimberger, Mohamed Abou-Ghazal, Chantal Reina-Ortiz, David S. Yang, Wei Sun
Clinical Cancer Research. 2008-08-15
430 citations
PD-L1 expression and prognostic impact in glioblastoma.
Edjah K. Nduom, Jun Wei, Nasser K. Yaghi, Neal Huang, Ling Yuan Kong
Neuro-Oncology. 2016-02-01
422 citations
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma.
Frederick F. Lang, Charles A. Conrad, Candelaria Gomez-Manzano, W. K. Alfred Yung, Raymond Sawaya
Journal of Clinical Oncology. 2018-02-12

Journal Articles

A Co-Clinical Radiogenomic Validation Study - Conserved Magnetic Resonance Radiomic Appearance of Periostin Expressing Glioblastoma in Patients and Xenograft Models
Sanjay K Singh, Ashok J Kumar, Rivka R Colen, Gregory N Fuller, Frederick F Lang, Erik P Sulman, Clinical Cancer Research

Lectures

The Role of Fibrinogen-like Protein 2 on Immunosuppression and Malignant Progression in Glioma
The University of Texas, M. D. Anderson Cancer Center, Houston, Texas - 1/19/2013

Oncogene Cooperation In Glioma GenesisNational Cancer Institute2010–2011
Dissecting Glioma Genesis Through A Glial-Specific Mouse ModelNational Cancer Institute2010–2011
Dissecting Glioma Genesis Through A Glial-Specific Mouse ModelNational Cancer Institute2009